Log in to save to my catalogue

Combination therapy with paricalcitol and trandolapril reduces renal fibrosis in obstructive nephrop...

Combination therapy with paricalcitol and trandolapril reduces renal fibrosis in obstructive nephrop...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5527548

Combination therapy with paricalcitol and trandolapril reduces renal fibrosis in obstructive nephropathy

About this item

Full title

Combination therapy with paricalcitol and trandolapril reduces renal fibrosis in obstructive nephropathy

Publisher

Basingstoke: Elsevier Inc

Journal title

Kidney international, 2009-12, Vol.76 (12), p.1248-1257

Language

English

Formats

Publication information

Publisher

Basingstoke: Elsevier Inc

More information

Scope and Contents

Contents

Growing evidence suggests that active vitamin D slows the progression of chronic kidney diseases. Here we compared the individual renal protective efficacy of paricalcitol and trandolapril (an angiotensin-converting enzyme inhibitor) in obstructive nephropathy, and examined any potential additive effects of their combination on attenuating renal fi...

Alternative Titles

Full title

Combination therapy with paricalcitol and trandolapril reduces renal fibrosis in obstructive nephropathy

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5527548

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5527548

Other Identifiers

ISSN

0085-2538

E-ISSN

1523-1755

DOI

10.1038/ki.2009.346

How to access this item